<DOC>
	<DOCNO>NCT02182687</DOCNO>
	<brief_summary>This study compare stereotactic body radiation therapy ( SBRT ) trans-arterial chemoembolization ( TACE ) bridge strategy patient HCC undergo orthotopic liver transplantation . We propose SBRT associate long time interval initial treatment need retreatment , compare TACE , `` bridge '' orthotopic liver transplantation .</brief_summary>
	<brief_title>Stereotactic Body Radiation Therapy ( SBRT ) Versus Trans-Arterial Chemoembolization ( TACE ) Bridge Liver Transplant</brief_title>
	<detailed_description>For patient hepatocellular carcinoma ( HCC ) wait liver transplant , local treatment disease become standard care effort decrease dropout rate mean reduce tumor recurrence transplantation . However , best modality patient undergoing treatment bridge transplantation unclear . This study compare stereotactic body radiation therapy ( SBRT ) trans-arterial chemoembolization ( TACE ) bridge strategy patient HCC undergo orthotopic liver transplantation . We propose SBRT associate long time interval initial treatment need retreatment , compare TACE , `` bridge '' orthotopic liver transplantation .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>Inclusion Criteria Patients hepatocellular carcinoma eligible trial . Hepatocellular carcinoma define least one following : Biopsy proven hepatocellular carcinoma ( HCC ) ; A discrete hepatic tumor ( ) define Barcelona ( 29 ) criterion cirrhotic patient , &gt; 2cm arterial hypervascularity venous delayed phase washout CT MRI . Patient within Milan Criteria `` list '' orthotopic liver transplantation . Patients must Zubrod performance status ≤2 . Patients must life expectancy least 12 week . Patients must 18 year age old . Adult patient age , sex race include study . Patients must ChildTurcottePugh ( CTP ) Class A Class B ( ≤ 7 ) . Female patient within reproductive year may , become , pregnant participation study . Both male female patient within reproductive year must agree use effective contraceptive method treatment . Women childbearing age require undergo urine serum pregnancy test ensure pregnant . Patients must adequate organ function within 2 week enrollment . Bone marrow : Platelets ≥30,000/mm3 Renal : BUN ≤40 mg/dl ; creatinine ≤2.0 mg/dl Hepatic : INR ≤ 1.5 correctable Vitamin K , unless anti coagulate another medical reason Bilirubin &lt; 3 mg/dl ( absence obstruction preexist disease biliary tract , e.g . primary sclerosing cholangitis ) Patients uninvolved liver volume estimate must &gt; 700ml . Patients must sign informed consent form approve purpose Institutional Review Board ( IRB ) Lahey Hospital Medical Center indicate aware investigational aspect treatment potential risk . Exclusion Criteria Patients `` special category '' designate Public Health Service , include patient young 18 , pregnant woman , prisoner . Refractory ascites ascites require paracentesis management . Patients solitary lesion great 5.0cm size 2 discrete lesion large great 3.0 cm size . Known allergy intravenous iodinate contrast agent unresponsive prednisone pretreatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hepatocellular carcinoma ( HCC )</keyword>
	<keyword>Orthotopic liver transplant</keyword>
	<keyword>Bridge transplant</keyword>
	<keyword>stereotactic body radiation therapy ( SBRT )</keyword>
	<keyword>trans-arterial chemoembolization ( TACE )</keyword>
</DOC>